Press Releases

If you have an interest in any investor relations, please contact us using the form below.

Name

Press Releases

Revita Revolutionizes Patient Care

Revita for wound care, by StimLabs, is the first intact placental membrane allograft on the market.

Placental allograft, cytology processor, cell-free RNA testing, and male infertility

Human placental allograft Revita, an allograft composed of human placental membrane, developed by Stimlabs, is available to ObGyns and other health care professionals for many uses including surgery and wound care. The human placental membrane is compos...

StimLabs Announces Department of Veterans Affairs (VA) And Department of Defense (DoD) ...

/PRNewswire/ -- StimLabs, LLC, a leader in regenerative technologies and products that are revolutionizing patient care, is pleased to announce availability of...

StimLabs Announces Enrollment of First Patient in Evaluating Efficacy of Full Thickness...

/PRNewswire/ -- StimLabs, a leader in regenerative technologies and products that are revolutionizing patient care, today announced that the first patient has...

StimLabs Announces Partnership with American Military Medical Organization, LLC

/PRNewswire/ -- StimLabs, LLC, a leader in regenerative technologies and products that are revolutionizing patient care, is pleased to announce a partnership...

StimLabs Enters Regenerative Medicine Market with Two Groundbreaking Amniotic Tissue Pr...

/PRNewswire/ -- StimLabs is announcing two revolutionary products in regenerative medicine. Revita®, the first full thickness placental membrane allograft in a...